Huennekens R Scott 4

What Happened

• R. Scott Huennekens, a director of NeuroPace, was granted two awards on 2026-06-05: 2,890 non-derivative shares and a derivative award covering 5,368 shares. Both were granted at a $0.00 acquisition price (total reported cash value $0). These are compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-06-05; Form 4 filed 2026-06-05 (Accession: 0001628280-26-041324).
• Transaction types/codes: A = Award/Grant (one non-derivative share award; one derivative award).
• Price: $0.00 for both grants; reported cash consideration $0.
• Vesting: Both awards vest in twelve (12) equal consecutive monthly installments, subject to continuous service (Footnotes F1 and F2).
• Shares owned after transaction: Not specified in the provided filing data.
• Timeliness: Filing date matches the transaction date (no late filing indicated).
• No 10b5-1 plan, tax-withholding sale, or immediate sale of shares reported.

Context

• The 5,368-share item is a derivative award (an option-style award per the footnote) that becomes exercisable as it vests; the 2,890-share award is non-derivative (e.g., restricted stock/RSU-style). These are compensation grants to a director and do not represent a market buy or sell decision. Such awards are common for board compensation and signal alignment with shareholder interests but are not direct purchases of stock.